Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2011

01-10-2011 | Article

Diversity of community acquired MRSA carrying the PVL gene in Queensland and New South Wales, Australia

Authors: M.-E. Costello, F. Huygens

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2011

Login to get access

Abstract

Emergence and dissemination of community acquired methicillin resistant Staphylococcus aureus (CA-MRSA) strains are being reported with increasing frequency in Australia and worldwide. These strains of CA-MRSA are genetically diverse and distinct in Australia. Genotyping of CA-MRSA using eight highly-discriminatory single nucleotide polymorphisms (SNPs) is a rapid and robust method for monitoring the dissemination of these strains in the community. In this study, a SNP genotyping method was used to investigate the molecular epidemiology of 249 community acquired non-multiresistant MRSA (nm-MRSA) isolates over a 12-month period from routine diagnostic specimens. A real-time PCR for the presence of Panton-Valentine leukocidin (PVL) was also performed on these isolates. The CA-MRSA isolates were sourced from a large private laboratory in Brisbane, Australia that serves a wide geographic region encompassing Queensland and Northern New South Wales. This study identified 16 different STs and 98% of the CA-MRSA isolates were positive for the PVL gene. The most common ST was ST93 with 41% of isolates testing positive for this clone.
Literature
1.
go back to reference Chambers HF (2005) Community-associated MRSA-resistance and virulence converge. N Engl J Med 352:1485–1487PubMedCrossRef Chambers HF (2005) Community-associated MRSA-resistance and virulence converge. N Engl J Med 352:1485–1487PubMedCrossRef
2.
go back to reference Chambers HF (2001) The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7:178–182PubMedCrossRef Chambers HF (2001) The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7:178–182PubMedCrossRef
3.
go back to reference Chambers HF (1997) Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 10:781–791PubMed Chambers HF (1997) Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 10:781–791PubMed
4.
go back to reference Coombs GW, Nimmo GR, Pearson JC, Christiansen KJ, Bell JM, Collignon PJ, McLaws ML, Australian Group for Antimicrobial Resistance (2009) Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients. Commun Dis Intell 1:10–20 Coombs GW, Nimmo GR, Pearson JC, Christiansen KJ, Bell JM, Collignon PJ, McLaws ML, Australian Group for Antimicrobial Resistance (2009) Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients. Commun Dis Intell 1:10–20
5.
go back to reference Coombs G, Nimmo G, Bell J, Huygens F, O’Brien F, Malkowski M, Pearson J, Stephens A, Giffard P (2004) Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia. J Clin Microbiol 42:4735–474CrossRef Coombs G, Nimmo G, Bell J, Huygens F, O’Brien F, Malkowski M, Pearson J, Stephens A, Giffard P (2004) Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia. J Clin Microbiol 42:4735–474CrossRef
6.
go back to reference Deurenberg RH, Stobberingh EE (2008) The evolution of Staphylococcus aureus. Infect Genet Evol 468:1348–1367 Deurenberg RH, Stobberingh EE (2008) The evolution of Staphylococcus aureus. Infect Genet Evol 468:1348–1367
7.
go back to reference Diep BA, Stone GG, Basuino L, Graber CJ, Miller A, des Etages SA, Jones A, Palazzolo-Balance AM, Perdreau-Remington F, Sensabaugh GF, DeLeo FR, Chambers HF (2008) The Arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis 197:1523–1530PubMedCrossRef Diep BA, Stone GG, Basuino L, Graber CJ, Miller A, des Etages SA, Jones A, Palazzolo-Balance AM, Perdreau-Remington F, Sensabaugh GF, DeLeo FR, Chambers HF (2008) The Arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis 197:1523–1530PubMedCrossRef
8.
go back to reference Diep BA, Otto M (2008) The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol 16:361–369PubMedCrossRef Diep BA, Otto M (2008) The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol 16:361–369PubMedCrossRef
9.
go back to reference Diep BA, Carleton HA, Chang RF, Sensabaugh GF, Perdreau-Remington F (2006) Roles of 34 virulence genes in the evolution of hospital-and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis 193:1495–1503PubMedCrossRef Diep BA, Carleton HA, Chang RF, Sensabaugh GF, Perdreau-Remington F (2006) Roles of 34 virulence genes in the evolution of hospital-and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis 193:1495–1503PubMedCrossRef
10.
go back to reference Diep BA, Gill SR, Chang RF, HaiVan Phan T, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F (2006) Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 367:731–739PubMedCrossRef Diep BA, Gill SR, Chang RF, HaiVan Phan T, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F (2006) Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 367:731–739PubMedCrossRef
11.
go back to reference Diep BA, Sensabaugh GF, Somboona NS, Carleton HA, Perdreau-Remington F (2004) Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol 42:2080–2084PubMedCrossRef Diep BA, Sensabaugh GF, Somboona NS, Carleton HA, Perdreau-Remington F (2004) Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol 42:2080–2084PubMedCrossRef
12.
go back to reference Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt B (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci 99:7687–7692PubMedCrossRef Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt B (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci 99:7687–7692PubMedCrossRef
13.
go back to reference Huygens F, Inman-Bamber J, Nimmo G, Munckhof W, Schooneveldt J, Harrison B, McMahon J, Giffard P (2006) Staphyloccus aureus genotyping using novel real-time PCR formats. J Clin Microbiol 44:3712–3719PubMedCrossRef Huygens F, Inman-Bamber J, Nimmo G, Munckhof W, Schooneveldt J, Harrison B, McMahon J, Giffard P (2006) Staphyloccus aureus genotyping using novel real-time PCR formats. J Clin Microbiol 44:3712–3719PubMedCrossRef
14.
go back to reference Huygens F, Stephens AJ, Nimmo GR, Giffard PM (2004) mecA locus diversity in methicillin-resistant Staphylococcus aureus isolates in Brisbane, Australia, and the development of a novel diagnostic procedure for the Western Samoan phage pattern clone. J Clin Microbiol 42:1947–1955PubMedCrossRef Huygens F, Stephens AJ, Nimmo GR, Giffard PM (2004) mecA locus diversity in methicillin-resistant Staphylococcus aureus isolates in Brisbane, Australia, and the development of a novel diagnostic procedure for the Western Samoan phage pattern clone. J Clin Microbiol 42:1947–1955PubMedCrossRef
15.
go back to reference McDonald M, Dougall A, Holt D, Huygens F, Oppedisano F, Giffard P, Inman-Bamber J, Stephens A, Towers R, Carapetis J, Currie B (2006) Use of a single-nucleotide polymorphism genotyping system to demonstrate the unique epidemiology of methicillin-resistant Staphylococcus aureus in remote aboriginal communities. J Clin Microbiol 44:3720–3727PubMedCrossRef McDonald M, Dougall A, Holt D, Huygens F, Oppedisano F, Giffard P, Inman-Bamber J, Stephens A, Towers R, Carapetis J, Currie B (2006) Use of a single-nucleotide polymorphism genotyping system to demonstrate the unique epidemiology of methicillin-resistant Staphylococcus aureus in remote aboriginal communities. J Clin Microbiol 44:3720–3727PubMedCrossRef
16.
go back to reference Munckhof WJ, Schooneveldt JM, Schlebusch S, Stephens AJ, Willians G, Huygens F, Giffard P (2009) Nasal carriage of Staphylococcus aureus, including community-associated methicillin-resistant strains, in Queensland adults. Clin Microbiol Infect 15:149–155PubMedCrossRef Munckhof WJ, Schooneveldt JM, Schlebusch S, Stephens AJ, Willians G, Huygens F, Giffard P (2009) Nasal carriage of Staphylococcus aureus, including community-associated methicillin-resistant strains, in Queensland adults. Clin Microbiol Infect 15:149–155PubMedCrossRef
17.
go back to reference Munckhof WJ, Schooneveldt J, Coombs GW, Hoare J, Nimmo GR (2003) Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia. Int J Infect Dis 7:259–267PubMedCrossRef Munckhof WJ, Schooneveldt J, Coombs GW, Hoare J, Nimmo GR (2003) Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia. Int J Infect Dis 7:259–267PubMedCrossRef
18.
go back to reference Munckhof WJ, Nimmo GR, Caney J, Schooneveldt JM, Huygens F, Inman-bamber J, Tong E, Morton A, Giffard P (2008) Methicillin-susceptible, non-multiresistant methicillin-resistant and mulitresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. Eur J Clin Microbiol 27:355–364CrossRef Munckhof WJ, Nimmo GR, Caney J, Schooneveldt JM, Huygens F, Inman-bamber J, Tong E, Morton A, Giffard P (2008) Methicillin-susceptible, non-multiresistant methicillin-resistant and mulitresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. Eur J Clin Microbiol 27:355–364CrossRef
19.
go back to reference Nimmo GR, Coombs GW (2008) Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia. Int J Antimicrob Agents 31:401–410PubMedCrossRef Nimmo GR, Coombs GW (2008) Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia. Int J Antimicrob Agents 31:401–410PubMedCrossRef
20.
go back to reference Nimmo GR, Coombs GW, Pearson JC, O'Brien FG, Christiansen KJ, Turnidge JD, Gosbell IB, Collignon P, McLaws ML (2006) Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. Med J Aust 184:384–388PubMed Nimmo GR, Coombs GW, Pearson JC, O'Brien FG, Christiansen KJ, Turnidge JD, Gosbell IB, Collignon P, McLaws ML (2006) Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. Med J Aust 184:384–388PubMed
21.
go back to reference Nimmo GR, Schooneveldt J, O’Kane G, McCall B, Vickery A (2000) Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in Southeast Queensland Australia. J Clin Microbiol 38:3926–3931PubMed Nimmo GR, Schooneveldt J, O’Kane G, McCall B, Vickery A (2000) Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in Southeast Queensland Australia. J Clin Microbiol 38:3926–3931PubMed
22.
go back to reference O’Hara F, Guex N, Word J, Miller L, Becker J, Walsh S, Scangarella N, West J, Shawar R, Amrine-Madsen H (2008) A geographic variant of the Staphyloccus aureus Panton-Valentine leukocidin toxin and the origin of community-associated methicillin-resistant S. aureus USA300. J Infect Dis 197:187–194PubMedCrossRef O’Hara F, Guex N, Word J, Miller L, Becker J, Walsh S, Scangarella N, West J, Shawar R, Amrine-Madsen H (2008) A geographic variant of the Staphyloccus aureus Panton-Valentine leukocidin toxin and the origin of community-associated methicillin-resistant S. aureus USA300. J Infect Dis 197:187–194PubMedCrossRef
23.
go back to reference Stephens A, Huygens F, Inman-bamber J, Price EP, Nimmo GR, Schooneveldt J, Munckhof W, Giffard P (2006) Methicillin-resistant Staphylococcus aureus genotyping using a small set of polymorphisms. J Med Microbiol 55:43–51PubMedCrossRef Stephens A, Huygens F, Inman-bamber J, Price EP, Nimmo GR, Schooneveldt J, Munckhof W, Giffard P (2006) Methicillin-resistant Staphylococcus aureus genotyping using a small set of polymorphisms. J Med Microbiol 55:43–51PubMedCrossRef
24.
go back to reference Vandenesch F, Naimi T, Enright M, Lina G, Nimmo G, Heffenman H, Liassine N, Bes M, Greenland T, Reverdy M, Etienne J (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9:978–984PubMed Vandenesch F, Naimi T, Enright M, Lina G, Nimmo G, Heffenman H, Liassine N, Bes M, Greenland T, Reverdy M, Etienne J (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9:978–984PubMed
Metadata
Title
Diversity of community acquired MRSA carrying the PVL gene in Queensland and New South Wales, Australia
Authors
M.-E. Costello
F. Huygens
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2011
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1203-4

Other articles of this Issue 10/2011

European Journal of Clinical Microbiology & Infectious Diseases 10/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine